<DOC>
	<DOCNO>NCT03065543</DOCNO>
	<brief_summary>A study conduct evaluate efficacy lipid-lowering therapy patient high high risk treat interventional cardiology . Study endpoint : 1 . Achievement target LDL-C 1-year follow-up LDL-C &lt; 70 mg / dl group high-risk LDL-C &lt; 100 mg / dL high-risk patient 2 . Assessment lipid profile severity coronary artery disease patient undergo invasive diagnosis coronary artery disease 3 . Evaluation trend treatment lipid-lowering patient different year</brief_summary>
	<brief_title>Hyperlipidemia Therapy TERCET Zabrze Registry</brief_title>
	<detailed_description>The TERCET Zabrze Registry observational study patient hospitalize due cardiovascular disease . The date include information hyperlipidaemia treatment , clinical characteristic , treatment modality prognosis population . Data collection patient-based ( event-based ) . The study population form all-comer patient hospitalize cardiology ward intensive cardiac care unit diagnosis coronary disease , stable angina , acute coronary syndrome ( ACS ) . For purpose study hyperlipidaemia define accordance European Society Cardiology guideline . Complete patient demographic ; medical history , complete hospitalization data ( diagnostic therapeutic ) , in-hospital out-hospital result collect electronic form attend physician . The patient constant follow-up cause mortality major adverse event .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>All patient coronary artery disease hyperlipidemia No coronary artery disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hyperlipidemias</keyword>
	<keyword>Secondary prevention</keyword>
	<keyword>high risk patient</keyword>
	<keyword>high risk patient</keyword>
</DOC>